Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Juneja

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Scientific Reports|July 21, 2016
Hypoxia-mediated impaired erythrocyte Lands' Cycle is pathogenic for sickle cell diseaseHongyu Wu, Mikhail Bogdanov, Yujin Zhang, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
Stem Cells (Dayton, Ohio)|September 19, 2019
Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical TrialFarhaan S Vahidy, Muhammad E Haque, Mohammad H Rahbar, et al.
IJTLD Open|May 14, 2025
Treatment success rate and time to culture conversion under a prospective BPaL cohort studyE Burhan, J Sugiharto, M Soemarno, et al.
Plos One|November 19, 2024
Introducing BPaL: Experiences from countries supported under the LIFT-TB projectD F Wares, M Mbenga, V Mirtskhulava, et al.
BMC Public Health|July 17, 2021
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patientsS E J van de Berg, P T Pelzer, A J van der Land, et al.
The Journal of Clinical Investigation|May 20, 2014
Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progressionYujin Zhang, Vladimir Berka, Anren Song, et al.
Scientific Reports|November 12, 2017
Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell DiseaseKaiqi Sun, Angelo D'Alessandro, Mostafa H Ahmed, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Scientific Reports|July 21, 2016
Hypoxia-mediated impaired erythrocyte Lands' Cycle is pathogenic for sickle cell diseaseHongyu Wu, Mikhail Bogdanov, Yujin Zhang, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
Stem Cells (Dayton, Ohio)|September 19, 2019
Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical TrialFarhaan S Vahidy, Muhammad E Haque, Mohammad H Rahbar, et al.
IJTLD Open|May 14, 2025
Treatment success rate and time to culture conversion under a prospective BPaL cohort studyE Burhan, J Sugiharto, M Soemarno, et al.
Plos One|November 19, 2024
Introducing BPaL: Experiences from countries supported under the LIFT-TB projectD F Wares, M Mbenga, V Mirtskhulava, et al.
BMC Public Health|July 17, 2021
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patientsS E J van de Berg, P T Pelzer, A J van der Land, et al.
The Journal of Clinical Investigation|May 20, 2014
Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progressionYujin Zhang, Vladimir Berka, Anren Song, et al.
Scientific Reports|November 12, 2017
Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell DiseaseKaiqi Sun, Angelo D'Alessandro, Mostafa H Ahmed, et al.
Pageof 15